Hangzhou Calibra Diagnostics Co., Ltd.
PrivateLast Round
Series C
Extension
Dec 27, 2022
Total Funding Raised
$65.08M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hangzhou Calibra Diagnostics Co., Ltd. is a biotechnology company that provides clinical mass spectrometry solutions, reagents, consumables, and laboratory services for precision medicine and multi-omics research.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Precision Medicine, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Calibra Diagnostics Co., Ltd. Comparables
Compare Hangzhou Calibra Diagnostics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shandong Yingsheng Biotechnology Co., Ltd. | 87% | |
| Hangzhou Well-healthcare Technologies Co., Ltd. | 86% | |
| Shanghai Reigncom Biotech Co., Ltd. | 85% |
Hangzhou Calibra Diagnostics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Dec 27, 2022 | ||||
| Series C | May 5, 2022 | ||||
| Series B | Feb 24, 2021 | ||||
| Series A | Sep 1, 2020 | ||||
| Angel | Dec 1, 2016 |
Hangzhou Calibra Diagnostics Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyuan Capital | Series A |
| Delian Capital | Series B |
| 松禾资本 (Green Pine Capital Partners) | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Monthly visitors increased 521% MoM, reaching 6.1K.
- Dec 27, 2022
Raised $4.29M in Series C Extension funding.
Hangzhou Calibra Diagnostics Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hangzhou Calibra Diagnostics Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou Calibra Diagnostics Co., Ltd. a public or private company?
Hangzhou Calibra Diagnostics Co., Ltd. is a private company.
What is the current stock price of Hangzhou Calibra Diagnostics Co., Ltd.?
Hangzhou Calibra Diagnostics Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Hangzhou Calibra Diagnostics Co., Ltd. worth (valuation)?
Valuation information for Hangzhou Calibra Diagnostics Co., Ltd. is not publicly available.
Can I buy Hangzhou Calibra Diagnostics Co., Ltd. stock?
Hangzhou Calibra Diagnostics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hangzhou Calibra Diagnostics Co., Ltd.'s last funding round?
Hangzhou Calibra Diagnostics Co., Ltd.'s most recent funding round was Series C Extension on December 27, 2022.
Who are the main investors in Hangzhou Calibra Diagnostics Co., Ltd.?
Key investors in Hangzhou Calibra Diagnostics Co., Ltd. include Boyuan Capital.
Will Hangzhou Calibra Diagnostics Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Calibra Diagnostics Co., Ltd..
How can I track Hangzhou Calibra Diagnostics Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou Calibra Diagnostics Co., Ltd.'s secondary market activity and sign up for updates.